自拟通脑活络汤治疗缺血性中风的临床研究

Clinical study on treating ischemic stroke with the Tongnao Huoluo decoction

目的:观察自拟通脑活络汤治疗缺血性中风(以下简称为中风)的的临床疗效。方法:将100例中风患者随机分为观察组和对照组各50例。对照组给予抗小板药肠溶阿司匹林口服,并根据患者血压血糖情况给予对症处理,观察组在对照组治疗基础上给予自拟通脑活络汤。观察其治疗前后TCD、彩超检查、血液流变学检查及疗效评分情况。结果:对照组的总有效率是76.0%,显著低于观察组的94.0%,差异有统计学意义(P<0.05);观察组TCD、彩超检查、血液流变学检查及临床疗效评分等相关指标均比治疗前显著降低,明显优于对照组(P<0.05)。结论:自拟通脑活络汤治疗中风疗效显著,可以降低病残率和病死率,改善患者偏瘫肢体的功能,提高患者的生存质量。

Objective： To observe the clinical effects of the Tongnao Huoluo decoction on treating ischemic stroke. Methods： 100 cases were randomly divided into the observation group and the control group, 50 cases for each. The control group was given anti-platelet medicines aspirin orally, and given symptomatic treatment according to blood pressure and blood sugar, the observation group was given the Tongnao Huoluo decoction on the basis of treatment of the control group. Before and after treatment TCD, ultrasound examination, blood examination and efficacy score situation were observed. Results： The total efficiency of the control group was 76.0%, significantly lower than 94.0% of the observation group, difference was statistically significant （P〈0.05）; TCD, ultrasound examination, blood examination and clinical efficacy ratings and other related indicators of the observation group significantly lower than before treatment, and significantly better than that of the control group （P〈0.05）. Conclusion： The Tongnao Huoluo decoction had a significant effect on treating stroke, could reduce morbidity and mortality and improve physical function in patients with hemiplegia, improve the patient＇s quality of life.